Table 3.
Study characteristics, surgical details and postoperative outcomes of literature on prophylactic mesh placement in primary radical cystectomy and ileal conduit urinary diversion
| General characteristics* | Surgical details* | Postoperative outcome* | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author & Year | Country | Study period | Study design | Sample size | Mean age | Male (%) | MIN- ORS | Tech- nique | Appr | Mesh position | Mesh type | Length of follow-up | Type of follow-up | PSH rate | Compl. rate | Mesh- related compl |
| Donahue 2016 | USA | 2013–2015 | RS | 33 | NR | 51.5% | 5 | Key-hole | Open | Retro-rectus | large pore, light weight | 297 days | Clinical + CT |
Clin: 3% CT: 18.2% |
NR | 0.0% |
| Liedberg 2020 | Sweden | 2012–2017 | RCT | C:124 M:118 | C: 71 M: 71 |
C: 79% M: 77% |
21 | Key-hole | Open | Retro-rectus | large pore, light weight | 3 years | Clinical + CT |
C: 29.3% M: 10.2% |
C: 41.5%M: 43.1% | NR |
| Styrke 2015 | Sweden | 2003–2012 | RS | 58 | 69 ± 7 | 59.0% | 10 | Key-hole | Open | Retro-rectus | large pore, light weight | 32mon | Clinical + CT | 14.0% | NR | 0.0% |
| Tenzel 2018 | USA | 2010–2017 | RS | C: 20 M: 18 | 68 | 74.0% | 10 | Key-hole | Rob | Retro-rectus | synthetic resorbable/bio | C: 21mon M: 11mon | CT |
C: 5% M: 0% |
NR | 0.0% |
| Jian 2021 (CA) | USA | 2019–2021 | RS | 38 | NR | NR | NA | Key-hole | Rob | Retro-rectus | medium weight, mono-filament | 5 months (n = 21) | CT (n = 21) | 5.0% | NR | 0.0% |
*: numbers within brackets indicate ranges, unless otherwise stated
CA conference abstract, C control (no mesh), M mesh, RS retrospective PS prospective, NC nationwide cohort, NR not reported, m months, CT Computed-Tomography scan, SD standard deviation, US ultrasonography